Serotonin Receptors in Alzheimer's Disease
Author Information
Author(s): Lorke Dietrich E, Lu Gang, Cho Eric, Yew David T
Primary Institution: Department of Anatomy, Faculty of Medicine and Health Sciences, UAE University
Hypothesis
Alterations of the serotonergic system contribute to neuropsychiatric symptoms in Alzheimer disease.
Conclusion
A decline in neurons expressing 5-HT2A and 5-HT6 receptors may play a role in the neuropsychiatric symptoms of Alzheimer's disease.
Supporting Evidence
- 5-HT2A receptor density was significantly reduced by 33% in Alzheimer's patients compared to normal aging patients.
- 5-HT6 receptor expression in Alzheimer's patients was significantly decreased by 40%.
- The study indicates a selective vulnerability of neurons receiving serotonergic input in Alzheimer's disease.
Takeaway
This study found that people with Alzheimer's disease have fewer serotonin receptors in their brains, which might explain some of their symptoms.
Methodology
Immunohistochemistry was used to determine the expression of 5-HT2A and 5-HT6 receptors in the prefrontal cortex of Alzheimer patients and age-matched controls.
Limitations
The study is limited by the small sample size and the advanced age of the patients, which may affect receptor expression.
Participant Demographics
6 Alzheimer patients (mean age: 88 years) and 7 normal aging controls matched for age and gender.
Statistical Information
P-Value
0.001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website